Regulatory T Cell Therapy for Autoimmune Disease

키워드

참고문헌 (156)

1. Gershon RK, "Suppressor T cells", J Immunol, 108, pp.586~590 (1972)
2. Gershon RK, "Infectious immunological tolerance", Immunology, 21, pp.903~914 (1971)
3. Ha TY, "Role of the thymus in tolerance .X. “Suppressor” activity of antigen-stimulated rat thymocytes transferred to normal recipients", J Immunol, 110, pp.1290~1299 (1973)
4. Ha TY, "Thymic suppressor cell. I. Separation of subpopulation with suppressor activity", J Exp Med, 139, pp.13~23 (1974)
5. Ha TY, "The thymic suppressor cell. II. Metabolic requirement of suppressor activity", Immunol Commun, 3, pp.351~359 (1974)
6. Tada T, "Properties of primed suppressor T cells and their products", Transplant Rev, 26, pp.106~129 (1975)
7. Gershon RK, "Contrasuppression. A novel immunoregulatory activity", J Exp Med, 153, pp.1533~1546 (1981)
8. Gerber NL, "Loss with age in NZB", W mice of thymic suppressor cells in the graft-vs-host reaction, 1974, pp.113, 1618~1625
9. Durkin HG, "Thymus and tolerance. Is regulation the major function of the thymus?", Immunol Rev, 182, pp.33~57 (2001)
10. Dorf ME, "Suppressor cells and immunoregulation", Ann Rev Immunol, 2, pp.127~158 (1984)
11. Mitrrücker HW, "Mini-review: regulatory T cells and infection: suppression revisited", Eur J Immunol, 34, pp.306~312 (2004)
12. Baecher-Allan C, "Suppressor T cells in human diseases", J Exp Med, 200, pp.273~276 (2004)
13. Waksman BH, "Tolerance, the thymus, and suppressor T cells", Clin Exp Immunol, 28, pp.363~374 (1977)
14. Shevach EM, "D4+: CD4+ CD25+ suppressor T cells: more questions than answers", Nat Rev Immunol, 182, pp.389~400 (2002)
15. BARRY T. ROUSE, "Regulatory T Cells and Infectious Disease", Immune Network, 7(4), pp.167~172 (2007), 대한면역학회
16. Basten A, "Special regulatory T-cell review: T cell dependent suppression revisited", Immunol, 123, pp.33~39 (2008)
17. Tang Q, "The Foxp3+ regulatory T cell: a jack of all trades, master of regulation", Nat Immunol, 9, pp.239~244 (2008)
18. Ha TY, "Effect of cyclophosphamide on humoral and cellular immune response in mice", J Korean Med Ass, 20, pp.985~994 (1977)
19. Ha TY, "Effect of dexamethasone on different types of murine T suppressor cells", Korean J Immunol, 9, pp.1~15 (1987)
20. Ha TY, "Regulation of cellular immunity in cryptococosis. III. Induction of Cryptococcus neoformans-specific T cells and hybridoma", Korean J Immunol, 14, pp.15~23 (1992)
21. Moeller G, "Suppressor T lymphocytes", Transplantation Rev, 26, pp.3~205 (1975)
22. Sakaguchi S, "Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanisms of self-tolerance causes various autoimmune diseases", J Immunol, 155, pp.1151~1164 (1995)
23. Sakaguchi S, "Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses", Ann Rev Immunol, 22, pp.531~562 (2004)
24. Mills KH, "Regulatory T cells: friend or foe in immunity to infection?", Nature Rev Immunol, 4, pp.841~855 (2004)
25. Stein-Streilein J, "An eye’s view of T regulatory cells", J Leukoc Biol, 81, pp.593~598 (2007)
26. Jiang S, "CD4+CD25+regulatory T-cell therapy for allergy, autoimmune and transplant rejection", Inflamm Allergy Drug Targets, 5, pp.239~242 (2006)
27. Beyer M, "Regulatory T cells in cancer", Blood, 1108, pp.804~811 (2006)
28. Bluestone JA, "Regulatory T-cell therapy: is it ready for the clinic?", Nat Rev Immunol, 5, pp.343~349 (2005)
29. Vignail DA, "How regulatory T cell work", Nat Rev Immunol, 8, pp.523~532 (2008)
30. Bendelac A, "The biology of NKT cells", Ann Rev Immunol, 25, pp.297~336 (2007)
31. Sakaguchi S, "Emerging challenges in regulatory T cell function and biology", Science, 317, pp.627~629 (2007)
32. Kang SM, "CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects", Am J Transplant, 7, pp.1457~1463 (2007)
33. Thomson CW, "Double-negative regulatory T cells: non-conventional regulators", Immunol Res, 35, pp.163~178 (2006)
34. Hayday A, "Immunoregulation in the tissues by γδT cells", Nat Rev Immunol, 3, pp.233~242 (2003)
35. Zhang C, "The regulatory effect of natural killer cells: do "NK-reg cells" exist?", Cell Mol Immunol, 3, pp.241~254 (2006)
36. Hori S, "Foxp3: a critical regulator of the development and function of regulatory T cells", Microbes Infect, 6, pp.745~751 (2004)
37. Ziegler SE, "FOXP3: of mice and men", Ann Rev Immunol, 24, pp.209~226 (2006)
38. Stein-Streilein J, "An eye’s view of T regulatory cells", J Leukoc Biol, 81, pp.593~598 (2007)
39. Hawrylowicz CM, "Regulatory T cells and IL-10 in allergic inflammation", J Exp Med, 202, pp.1459~1463 (2005)
40. Zhang ZX, "Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression", Nat Med, 6, pp.782~789 (2000)
41. Ford McIntyre MS, "Cutting edge: in vivo trogocytosis as a mechanism of double negative regulatory T cell-mediated antigen-specific suppression", J Immunol, 181, pp.2271~2275 (2008)
42. Young KJ, "Inhibition of graft versus host disease by double negative regulatory T cells", J Immunol, 171, pp.134~141 (2003)
43. Morgan ME, "Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans", Human Immunol, 66, pp.13~20 (2005)
44. Sakaguchi S, "Fox3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease", Immunol Rev, 212, pp.8~27 (2006)
45. Dejaco C, "Imbalance of regulatory T cells in human autoimmune diseases", Immunology, 117, pp.289~300 (2006)
46. Venken K, "Compromised CD4+CD25high regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level", Immunology, 123, pp.79~89 (2008)
47. Zheng SG, "CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome", J Immunol, 172, pp.1531~1539 (2004)
48. Yamaguchi T, "Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor", Immunity, 27, pp.145~159 (2007)
49. Chen ML, "Latency-associated peptide identifies a novel CD4+CD25+ regulatory T cell subset with TGFβ-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis", J Immunol, 180, pp.7327~7337 (2008)
50. Bruder D, "Neuropilin-1: a surface marker of regulatory T cells", Eur J Immunol, 34, pp.623~630 (2004)
51. Glinka Y, "Neruopilin-1 is a receptor for transforming growth factor β-1, activates its latent form, and promotes regulatory T cell activity", J Leukoc Biol, 84, pp.302~310 (2008)
52. Coleman CA, "T regulatory cells: aid or hindrance in the clearance of disease?", J Cell Mol Med, 11, pp.1291~1325 (2007)
53. Sakaguchi S, "Emerging challenges in regulatory T cell function and biology", Science, 317, pp.627~629 (2007)
54. Bacchetta R, "Role of regulatory T cells and FOXP3 in human diseases", J Allergy Clin Immunol, 120, pp.227~235 (2007)
55. Sakaguchi S, "Organ-specific autoimmune disease induced in mice by elimination of T-cell subset. I. Evidence for the active participation of T-cells in natural self-tolerance: deficit of a T-cell subset as a possible cause of autioimmune disease", J Exp Med, 161, pp.72~87 (1985)
56. Gambinen E, "Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis", Curr Opin Reumatol, 15, pp.430~435 (2003)
57. Nardekku DT, "CD4(+)CD25(+) T cells prevent arthritis associated with Borrelia vaccination and infection", Clin Diag Lab Immunol, 12, pp.786~792 (2005)
58. Nguyen LT, "Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis", Arthritis Rheum, 56, pp.509~520 (2007)
59. Ehrenstein MR, "Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy", J Exp Med, 200, pp.277~285 (2004)
60. Broere F, "Oral or nasal antigen induces regulatory T cells that suppress arthritis and proliferation of arthritogenic T cells in joint draining lymph nodes", J Immunol, 181, pp.899~906 (2008)
61. Förger F, "Pregnancy induces numerical and funtinal changes of CD4+CD25high regulatory T cells in patients with rheumatoid arthritis", Ann Rheum Dis, 67, pp.984~990 (2008)
62. Kelchtemans H, "Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis", Ann Rheum Dis (2008)
63. von Boehmer H, "Can studies of tolerance ever lead to therapy?", Ann Rheum Dis, 65(3), pp.iii41~iii43 (2006)
64. Leipe J, "Regulatory T cells in rheumatoid arthritis", Arthritis Res Ther, 7, pp.93~ (2005)
65. Wang J, "Mechanisms of oral tolerance revisited", Arthritis Res Ther, 10, pp.108~109 (2008)
66. Liu MF, "The presence of cytokine-suppressive CD4+CD25+ T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis", Scand J Immunol, 62, pp.312~317 (2005)
67. Cao D, "CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease", Arthritis Res Ther, 6, pp.R335~R346 (2004)
68. Behrens F, "Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis", Ann Rheum Dis, 66, pp.1151~1156 (2007)
69. Cao D, "FOXP3 identifies regulatory CD25bright CD4+ T cells in rheumatic joints", Scand J Immunol, 63, pp.444~452 (2006)
70. Park MJ, "Indoleamine 2,3-dioxygenase-expresssing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer’s patches in an orally tolerized, collagen-induced arthritis mouse model", Arthritis Res Ther, 10, pp.R11~ (2008)
71. Ehrenstein MR, "Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy", J Exp Med, 200, pp.277~285 (2004)
72. Morgan ME, "Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells", Arthritis Rheum, 52, pp.2212~2221 (2005)
73. Nguyen LT, "Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis", Arthritis Rheum, 56, pp.509~520 (2007)
74. Sarkar S, "Regulatory T cell defects in rheumatoid arthritis", Arthritis Rheum, 56, pp.710~713 (2007)
75. Godebu E, "Polyclonal adaptive regulatory CD4 cells that can reverse type 1 diabetes become oligoclonal long-term protective memory cells", J Immunol, 181, pp.1798~1805 (2008)
76. Tritt M, "Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes", Diabetes, 57, pp.113~123 (2008)
77. Tang Q, "in vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes", J Exp Med, 199, pp.1455~1465 (2004)
78. Tarbell KV, "CD25+CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes", J Exp Med, 199, pp.1467~1477 (2004)
79. Masteller EL, "Expansion of functional endogenous antien-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice", J Immunol, 175, pp.3053~3059 (2005)
80. Tiittanen M, "Insulin treatment in patients with type 1 diabetes induces upregulation of regulatory T-cell markers in peripheral blood mononuclear cells stimulated with insulin in vitro", Diabetes, 55, pp.3446~3454 (2006)
81. Richer MJ, "Regulatory T-cells protect from type 1 diabetes after induction by Coxsackievirus infection in the context of transforming growth factor-β", Diabetes, 57, pp.1302~1311 (2008)
82. Gregori S, "Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development", J Immunol, 171, pp.4040~4047 (2003)
83. Kanagawa O, "Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice", J Immunol, 168, pp.6159~6164 (2002)
84. Jaeckel E, "Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes", Diabetes, 54, pp.306~310 (2005)
85. Lee VW, "Regulatory immune cells in kidney disease", Am J Physiol Renal Physiol, 295, pp.F335~F342 (2008)
86. Noris M, "Regulatory T cells and T cell depletion: role of immunosuppressive drugs", J Am Soc Nephrol, 18, pp.1007~1018 (2007)
87. Wolf D, "CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice", J Am Soc Nephrol, 16, pp.1360~1370 (2005)
88. Mahajan D, "CD4+CD25+ regulatory T cell protect against injury in an innate murine model of chronic kidney disease", J Am Soc Nephrol, 17, pp.2731~2741 (2006)
89. Wang YM, "Foxp3-transduced polyclonal regulatory T cells protect against chronic renal injury from adriamycin", J Am Soc Nephrol, 17, pp.697~706 (2006)
90. Salma AD, "Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture’s (anti-GBM) disease", Kidney Int, 64, pp.1685~1694 (2003)
91. Mekal DJ, "IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes", Proc Natl Acad Sci USA, 102, pp.11817~11822 (2005)
92. Selvaraj RK, "Mitigation of experimental allergic encephalomyelitis by TGF-β induced Foxp3+ regulatory T lymphocytes through the induction of anergy and infectious tolerance", J Immunol, 180, pp.2830~2838 (2008)
93. Ochoa-Repáraz J, "Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyelitis", J Immunol, 178, pp.1791~1799 (2007)
94. Mekala DJ, "Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes", Blood, 105, pp.2090~2092 (2005)
95. Ochoa-Repáraz J, "IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen", J Immunol, 181, pp.954~968 (2008)
96. Wang J, "Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population", Proc Natl Acad Sci U S A, 105, pp.3915~3920 (2008)
97. Suvas S, "CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses", J Exp Med, 198, pp.889~901 (2003)
98. Kohm AP, "Cutting edge: CD4+CD25+ regulatory T cells suppress antigen- specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis", J Immunol, 169, pp.4712~4716 (2002)
99. Gonzalez-Rey E, "Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis; down-regulaltion of inflammatory and autoimmune responses", Am J Pathol, 168, pp.1179~1188 (2006)
100. Char JG, "in vitro expansion improves in vivo regulation by CD4+CD25+ regulatory T cells", J Immunol, 180, pp.858~869 (2008)
101. Venken K, "Natural naive CD4+CD25+ CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression", J Immunol, 180, pp.6411~6420 (2008)
102. Venken K, "Compromised CD4+CD25high regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 exxpression at the single-cell level", Immunology, 123, pp.79~89 (2008)
103. Saresella M, "CD4+CD25+Fox3+ PD-regulatory T cells in acute and stable elapsing-remitting multiple sclerosis and their modulation by therapy", FASEB, 22, pp.3500~3508 (2008)
104. Zozulya AL, "The role of regulatory T cells in multiple sclerosis", Nat Clin Prat Neurol, 4, pp.384~398 (2008)
105. Anderton SM, "Regulatory T cells in the control of inflammatory demyelingating diseases of the central nervous system", Curr Opin Neurol, 21, pp.248~254 (2008)
106. Danese S, "The Janus faces of CD4+CD25+ regulatory T cells in cancer and autoimmunity", Curr Med Chem, 14, pp.649~666 (2007)
107. Suárez A, "Enrichment of CD4+CD25high T cell population in SLE patients treated with glucocorticoids", Ann Rheum Dis, 65, pp.1512~1517 (2006)
108. Mellor-Pita S, "Decrease of regulatory T cells in patients with systemic lupus erythematosus", Ann Rheum Dis, 65, pp.553~554 (2006)
109. LaCava A, "T-regulatory cells in systemic lupus erythematosus", Lupus, 17, pp.421~425 (2008)
110. Lee HY, "Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus", Rheumatology (Oxford), 47, pp.789~794 (2008)
111. Azba NA, "CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematousus (SLE) patients: the possible influence of treatment with corticosteroids", Clin Immunol, 127, pp.151~157 (2008)
112. Kang HK, "Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets", J Immunol, 174, pp.3247~3255 (2005)
113. Parietti V, "Regulatory T cells and systemic lupus erythematosus", Ann N Y Acad Sci, 1108, pp.64~75 (2007)
114. Kang HK, "Regulatory T cells in lupus", Int Rev Immunol, 25, pp.5~25 (2006)
115. Valencia X, "Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus", J Immunol, 178, pp.2579~2588 (2007)
116. Braat H, "Prevention of experimental colitis by parenteral administration of a pathogen-derived immunomodulatory molecule", Gut, 56, pp.351~357 (2007)
117. Saruta M, "Characterization of FOXP3+CD4+ regulatory T cells in Crohn’s disease", Clin Immunol, 125, pp.281~290 (2007)
118. Coombes JL, "Control of intestinal homeostasis by regulatory T cells and dendritic cells", Seminars Immunol, 19, pp.116~126 (2007)
119. Mottet C, "cutting edge: cure of colitis by CD4+CD25+ regulatory T cells", J Immunol, 170, pp.3939~3943 (2003)
120. Denning TL, "Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis", J Immunol, 174, pp.7487~7491 (2005)
121. Uhlig HH, "Characterization of Foxp3+ CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis", J Immunol, 177, pp.5852~5860 (2006)
122. Sarkar S, "Regulatory T cell defects in rheumatoid arthritis", Arthritis Rheum, 56, pp.710~713 (2007)
123. DiPaola RJ, "CD4+CD25+T cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector T cells", J Immunol, 175, pp.7135~7142 (2005)
124. Stummvoll GH, "Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells", J Immunol, 181, pp.1908~1916 (2008)
125. Aricha R, "Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis", J Immunol, 180, pp.2132~2139 (2008)
126. Isaacs JD, "Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future", Rheumatology (Oxford), 47, pp.1461~1468 (2008)
127. Sheng JR, "Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis", Clin Immunol, 128, pp.172~180 (2008)
128. Meriggioli MN, "Strategies for treating auto immunity: novel insights from experimental myasthenia gravis", Ann N Y Acd Sci, 1132, pp.276~282 (2008)
129. Gang E, "IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-marcrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis", J Immunol, 174, pp.7006~7013 (2005)
130. Verginis P, "Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+ CD25+ T cells", J Immunol, 174, pp.7433~7439 (2005)
131. McLachlan SM, "The link between Graves’ disease and Hashimoto’s thyroiditis: a role for regulatory T cells", Endocrinology, 148, pp.5724~5733 (2007)
132. Solomou ED, "Deficient CD4+CD25+FOXP3+ T regulatory cells in acquired aplastic anemia", Blood, 110, pp.1603~1606 (2007)
133. Young NS, "Aplastic anemia", Curr Opin Hematol, 15, pp.162~168 (2008)
134. Wang J, "Mechanisms of oral tolerance revisited", Arthritis Res Ther, 10, pp.108~109 (2008)
135. Chorny A, "Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo: therapeutic applications in autoimmunity and transplantation", Ann NY Acad Sci, 1070, pp.190~195 (2006)
136. Delgado M, "Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo", J Leukc Biol, 78, pp.1327~1338 (2005)
137. Gonzalez-Rey E, "Vasoactive intestinal peptide induces CD4+, CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis", Arthritis Rheum, 54, pp.864~876 (2006)
138. Delgado M, "Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo", J Leukc Biol, 78, pp.1327~1338 (2005)
139. Delgado M, "in vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis", Arthritis Rheum, 58, pp.1026~1037 (2008)
140. Broere F, "Oral or nasal antigen induces regulatory T cells that suppress arthritis and proliferation of arthritogenic T cells in joint draining lymph nodes", J Immunol, 181, pp.899~906 (2008)
141. Förger F, "Pregnancy induces numerical and functional changes of CD4+CD25high regulatory T cells in patients with rheumatoid arthritis", Ann Rheum Dis, 67, pp.984~990 (2008)
142. Kelchtemans H, "Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis", Ann Rheum Dis (2008)
143. Radbruch A, "Cell therapy for autoimmune diseases: does it have a future?", Ann Rheumatic Dis, 63(2), pp.ii96~ii101 (2004)
144. O’connor RA, "Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease", J Neuroimmunol, 193, pp.1~11 (2008)
145. Que-Gewirth NS, "Gene therapy progress and prospects: RNA aptamers", Gene Ther, 14, pp.283~291 (2007)
146. Venken K, "Natural naive CD4+CD25+ CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression", J Immunol, 180, pp.6411~6420 (2008)
147. Reynolds AD, "Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease", J Leukoc Biol, 82, pp.1083~1094 (2007)
148. Karagiannidis C, "Glucoorticoids upregulated FOXP3 expression and regulatory T cells in asthma", J Allergy Clin Immunol, 114, pp.1425~1433 (2004)
149. Proft T, "Bacterial superantigens", Clin Exp Immunol, 133, pp.299~306 (2003)
150. Ou LS, "T regulatory cells in atopic dermatitis and subversion of their activity by superantigens", J Allergy Clin Immunol, 113, pp.756~763 (2004)
151. Goleva E, "Factors that regulate naturally occurring T regulatory cell-mediated suppression", J Allergy Clin Immunol, 116, pp.1000~1094 (2005)
152. Feunou P, "Foxp3+CD25+T regulatory cells stimulate IFN-gamma-independent CD152-mediated activation of tryptophan catabolisms that provides dendritic cells with immune regulatory activity in mice unresponsive to staphylococcal enterotoxin B", J Immunol, 179, pp.910~917 (2007)
153. Battaglia M, "Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells", Blood, 105, pp.4743~4748 (2005)
154. Chin KM, "Biologic correlates of response and survival in patients with cutaneous T cell lymphoma treated with denileukin diftitox", Clin Lymphoma Myeloma, 7, pp.199~204 (2006)
155. Battaglia M, "Rapamycin promotes expansion of functional CD4+CD25+ FOXP3+ regulatory T cells of both healthy subject and type 1 diabetic patients", J Immunol, 177, pp.8338~8347 (2006)
156. Mira E, "Statins induce regulatory T cell recruitment via CCL1 dependent pathway", J Immunol, 181, pp.3524~3534 (2008)

관련 논문AI추천